Autophagy links β-catenin and Smad signaling to promote epithelial-mesenchymal transition via upregulation of integrin linked kinase  by Pang, Min et al.
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TGF-1  induces  epithelial-mesenchymal  transition  (EMT)  and  autophagy  in a variety  of cells.  However,
the  role of autophagy  in  TGF-1-induced  EMT  has  not  been  clearly  elucidated  and  the  underlying  mech-
anisms  are  unclear.  In  the  present  study,  we  found  that  TGF-1  induced  both  autophagy  and  EMT  in
mouse  tubular  epithelial  C1.1  cells.  Inhibition  of  autophagy  by  3-methyladenine  or siRNA  knockdown  of
Beclin  1 reduced  TGF-1-induced  increase  of  vimentin  and  decreased  E-cadherin  expression.  In contrast,
rapamycin-associated  enhancement  of TGF-1-induced  autophagy  increased  EMT of  C1.1  cells.  Serum
rescue  inhibited  autophagy  followed  by  reversal  of  EMT.  Blocking  of  autophagosome-lysosomal  but  not
proteosomal  degradation  reduced  the  decrease  of E-cadherin,  demonstrating  a role  for autophagy  in
degradation  of E-cadherin  during  EMT.  Autophagy  promoted  the  activation  of Src  and  Src-associated
phosphorylation  of  -catenin  at Y-654  leading  to pY654--catenin/p-Smad2  complex  formation.  Chro--catenin
LK
matin  immunoprecipitation  assay  demonstrated  binding  by the  pY654--catenin/p-Smad2  complex
to  ILK  promoter  thus  increasing  ILK  expression.  Taken  together,  our  results  demonstrate  that  TGF-
1-induced  autophagy  links  -catenin  and  Smad  signaling  to promote  EMT  in C1.1  cells  through  a
novel  pY654--catenin/p-Smad2/ILK  pathway.  The  pathway  delineated  links  disruption  of  E-cadherin/-
catenin-mediated  cell–cell  contact  to  induction  of EMT  via  upregulation  of  ILK.
©  2016  The  Author(s).  Published  by  Elsevier  Ltd.  This  is  an open  access  article  under  the  CC  BY-NC-ND. Introduction
Autophagy is an evolutionally conserved physiological process
hich processes that involves the sequestration of cytosolic mate-
ial into double membrane vesicles termed autophagosomes for
elivery to the lysosome, where the cargo is degraded by acidic
ydrolases (Chen and Klionsky, 2011). In this process, autophagy
enerates intracellular nutrients, growth factors and energy to sup-
ort cell survival and cellular homeostasis during extracellular or
ntracellular stress due to causes such as starvation, hypoxia and
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.0/).license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
growth factor withdrawal (Levine and Kroemer, 2008; Mizushima
et al., 2008). Autophagic degradation is involved in a wide vari-
ety of physiological and pathophysiological processes including
development, aging, neurodegeneration, cancer, inﬂammation and
other diseases (Levine and Kroemer, 2008; Mizushima et al., 2008).
It functions as a cytoprotective or pro-death agent in a context-
dependent manner.
Renal interstitial ﬁbrosis is an inevitable outcome of all causes of
progressive chronic kidney disease (CKD) (Eddy, 2000). The process
of renal interstitial ﬁbrosis includes tubular atrophy, myoﬁbroblast
accumulation and ECM deposition. Epithelial-mesenchymal transi-
tion (EMT) is a key mechanism in the pathogenesis and progression
of renal interstitial ﬁbrosis (Barnes and Glass, 2011; Kriz et al.,
2011). Transforming growth factor (TGF)-1 is the key inducer of
EMT, acting via activation of downstream Smad signaling (Bottinger
and Bitzer, 2002). -catenin, a cell adhesion molecule expressed
e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
124 M. Pang et al. / The International Journal of Biochemistry & Cell Biology 76 (2016) 123–134
Fig. 1. TGF-1 induces autophagy and EMT  in C1.1 cells. (A) C1.1 cells were cultured on glass coverslips, treated with and without 5 ng/ml TGF-1 for 48 h, immune-labelled
with  a rabbit anti-beclin 1 (red), a rabbit anti-LC3-II antibody (green), a rabbit anti-E-cad antibody (green) or a rabbit anti-vimentin antibody and exposed to DAPI for nuclei
(blue). Scale bar, 25 m.  (B) C1.1 cells were treated with or without 5 ng/ml TGF-1 for 48 h, total proteins were extracted, and the levels of E-cad, vimentin, beclin 1, LC3-II,
cleaved caspase 3 and -actin were detected by Western blotting. Blots representative of three independent experiments are shown. Data are mean ± SD (n = 3) of three
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C3-II  was observed by a Confocal Laser Scanning Microscopy (left) and a punctuat
00  m.  **p  < 0.01 indicates signiﬁcant difference between groups as shown.
uring E-cadherin-mediated cell–cell contact, can promote EMT
pon nuclear translocation and binding to Smad2 or Smad3 as a
o-activator (Kim et al., 2009b; Tian et al., 2013). Importantly, TGF-
 cannot induce EMT  without disruption of E-cadherin-mediated
ell–cell contact (Masszi et al., 2004; Zheng et al., 2009).
TGF-1 also plays a key role in autophagy in a variety of cell
ypes (Ding and Choi, 2014; Liu et al., 2014). In cultured human
enal proximal tubular epithelial cells, TGF-1 activated autophagy
hrough generation of ROS, and promoted apoptosis (Xu et al.,
012). TGF-1 can induce both ﬁbrosis and autophagy, but the
elationship between these two biological processes is unclear.
oreover, the role of autophagy, if any, in EMT  is controversial.
utophagy has been shown to activate EMT  to promote hepa-
ocellular carcinoma cell invasion (Li et al., 2013). Others have
emonstrated that tubular epithelial cell overexpression of TGF-
1 induced dedifferentiation and decomposition of tubular cells by
utophagy, and led to the development of tubulointerstitial ﬁbrosis,
ithout evidence of EMT  (Koesters et al., 2010). More importantly,
LK has been proven to be a key mediator of TGF--induced EMT  by
cting downstream of Smads and upstream of Snail/Slug (Serrano
t al., 2013). However, genetic depletion of ILK (Dai et al., 2006)
eﬁned an opposite role for ILK to that of ILK overexpression or
nhibition studies (Kang et al., 2010). Absence of ILK/Richor com-
lex from normal epithelial cells compared with breast cancer cells
lso suggested that ILK may  have different functions via different
echanisms. In this study, we investigated the interrelationship
etween autophagy induced by TGF-1 and EMT  using mouse renal
ubular epithelial C1.1 cells. We  demonstrate for the ﬁrst time that
GF-1-induced autophagy links E-cadherin/-catenin-mediated
ell–cell contact to TGF-/Smad signaling to promote proﬁbroticated with or without 5 ng/ml TGF-1 for 48 h in serum-free media. Punctated GFP-
ttern was  shown (right), indicating appearance of autophagy. Scale bar represents
EMT  processes in C1.1 cells by pSmad2/pY654--catenin-mediated
upregulation of ILK.
2. Materials and methods
Cell culture and treatment
Mouse kidney proximal tubular epithelial C1.1 (SV40-
transformed) cells (Wahl et al., 2002) (a kind gift from the
laboratory of Dr Rudolf Wüthrich, Switzerland) were cultured
in DMEM:HAM’s F12 (1:1 v/v) medium (Invitrogen) containing
25 mg/ml  of EGF (Sigma), 25 mM of HEPES (Invitrogen), 5 mg/ml
insulin (Sigma), 1.25 ng/ml prostaglandin E1 (Cayman Chemicals),
0.0338 ng/ml 3,3,5-triiodothyonine (Sigma) 5 mg/ml hydrocor-
tisone (Sigma), 1.73 ng/ml transferrin(Sigma), 18 ng/ml sodium
selenite (Sigma) and 5% fetal calf serum (FCS)(Invitrogen) at 37 ◦C,
in 5% CO2. For treatment of C1.1 cells, the serum-supplemented
media was replaced with serum free media.
In experiments using treatment with TGF-1 (Invitrogen),
3-methyladenine (3-MA, Sigma), rapamycin, chloroquine (CQ,
Sigma), or ammonium chloride (NH4Cl, Sigma), subconﬂuent cul-
tures of C1.1 cells were rinsed with Dulbecco’s Phosphate Buffered
Saline Without Calcium or Magnesium (DPBS, Invitrogen) and then
treated with 5 ng/ml TGF-1, with or without 5 M 3-MA, 45 nM
rapamycin, 25 M CQ or 20 mM NH4Cl. For MG132 (Sigma) treat-
ment, cells were pretreated with or without 10 M MG132, and
then TGF-1 was  added for a further 48 h. In control experiments
the same volume DMSO vehicle was added in without rapamycin
or MG132 treatment. After treatment for 48 h, cells were harvested
for analysis over three independent experiments. For transfection
experiments, 2 × 105 cells were seeded into 6-well plates. After
the cells reached about 50–60% conﬂuence, Lipofectamine®LTX
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Fig. 2. TGF-1 induces autophagy and EMT  in both a dose-dependent and time-dependent manner (A) C1.1 cells were treated with or without various concentrations of
T clin 1
w nd th
b e mea
r
a
w
C
a
M
U
S
o
s
a
2
t
t
A
t
t
o
2
5
pGF-1  for 48 h, total proteins were extracted, and the levels of E-cad, vimentin, be
ith  or without 5 ng/ml TGF-1 for various times, total proteins were extracted, a
lotting. Blots representative of three independent experiments are shown. Data ar
eagent (Invitrogen) was used to transiently transfect C1.1 cells
ccording to the manufacturers’ protocols. F-TrCP-Ecad plasmid
as kindly provided by Dr Feng Cong (Memorial Sloan-Kettering
ancer Center, New York). Flag-tagged Smad7 fused into pcDNA3
nd GFP-LC3 were kindly provided by Dr Junbo Liang (Institute of
ateriaMedica, Chinese Academy of Medical Sciences and Peking
nion Medical College). siRNA for Beclin 1 was purchased from
anta Cruz. For serum rescue assays, C1.1 cells were treated with
r without TGF-1 for 48 h, and then cultured with the complete
erum-containing medium for indicated times. Cells were collected
nd analysed by Western blot assay.
.1. Flow cytometric analysis
Cells were exposed to 5 ng/ml TGF-1 for 48 h or 10 M Camp-
othecin (CPT) for 6 h as positive control to induce apoptosis. After
reatment, apoptosis analysis was performed using Annexin V–PE
poptosis Detection Kit (BD Biosciences)according to the manufac-
urer’s recommendations. The apoptotic cells were detected using
he Canto II ﬂow cytometer system and the percentage of cells (%
f total cells) was analysed using BD FACSDiva software.
.2. Immunoﬂuorescence staining and ﬂuorescence microscopyC1.1 cells were cultured on glass coverslips and treated with
 ng/ml TGF-1 for 48 h. Indirect immunoﬂuorescence staining was
erformed to assess autophagy and EMT. For assessing the p-Src, LC3-II and -actin were detected by Western blotting. (B) C1.1 cells were treated
e levels of E-cad, vimentin, beclin 1, LC3-II and -actin were detected by Western
n ± SD (n = 3) of three independent experiments. *p < 0.05.
expression, C1.1 cells were treated with 5 ng/ml TGF-1 for 2 h. For
assessing the ILK expression, C1.1 cells were pretreated with 5 M
3-MA or 45 nM rapamycin for 24 h, then treated with 5 ng/ml TGF-
1 for 48 h. Cells were washed twice with cold DPBS and ﬁxed with
cold methanol for 20 min  at room temperature. Following three
extensive washings with PBS, the cells were treated with 0.1% Tri-
ton X-100 in DPBS for 10 min  (for Vimentin, Beclin 1, LC3, p-Src (Cell
signal Technology) and ILK (Abcam) staining) or without Triton X-
100 treatment (for Ecad (Cell signal Technology) staining), and then
were blocked with 5% BSA (Sigma) in DPBS buffer for 30 min  at room
temperature. Cells were then incubated with primary antibodies
(1:50) diluted in 1% BSA in DPBS buffer at 4 ◦C overnight. After 3
times washes with DPBS, cells were incubated with Alexa Fluor®
488 goat anti-rabbit IgG (H + L) (1:200; Invitrogen) or Alexa Fluor®
546 goat anti-rabbit IgG (H + L) (1:400; Invitrogen) 1 h at room tem-
perature. Cells were washed 3 times with DPBS and nuclei were
counterstained by incubation with 4′,6-diamidino-2 phenylindole
(DAPI, Invitrogen) for 10 min, then washed again with DPBS before
mounting with ﬂuorescence mounting medium (Dako). Images
were captured using Spot Advanced version 3.4 (Diagnostic Instru-
ments Inc.) with a ﬂuorescence microscope (Olympus BX51) and
Spot RT Slider camera.
C1.1 cells were transfected with a plasmid expressing the green
ﬂuorescent protein (GFP)-LC3 using Lipofectamine TM 2000. After
24 h, cells were cultured with or without 5 ng/ml TGF-1 for
another 48 h in serum-free media. GFP-LC3 was detected by a
FV1000Confocal Laser Scanning Microscopy.
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Fig. 3. Autophagy promotes TGF-1 induced EMT  in C1.1 cells. C1.1 cells were pretreated with or without 5 M 3-MA (A), 10 M CQ (B), 45 nM rapamycin (C) or siRNA for
Beclin  1 (D) in presence or absence of 5 ng/ml TGF-1 for 24 h, then treated with or without 5 ng/ml TGF-1 alone for another 24 h. DMSO was used in control group. After
treatment, total proteins were extracted, and the levels of E-cad, vimentin, beclin 1, LC3-II, p62 and -actin were detected by Western blotting. (E) C1.1 cells were treated
with  or without 5 ng/ml TGF-1 for 48 h, then the serum-free medium was  replaced with complete medium and the culture continued for various times, total proteins were
extracted, and the levels of E-cad, vimentin, beclin 1, LC3-II and -actin were detected by Western blotting. Blots representative of three independent experiments are shown.
Data  are mean ± SD (n = 3) of three independent experiments. *p < 0.05.
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.3. Co-immunoprecipitation
Nuclear proteins were extracted using a NE-PER Nuclear and
ytoplasmic Extraction kit (Thermo Scientiﬁc) according to the
anufacturers’ instructions and then quantiﬁed by BCA assay
it (Thermo Scientiﬁc). Co-immunoprecipitation (Co-IP) was per-
ormed using the Protein-G Immunoprecipitation Kit (Invitrogen).
rieﬂy, 2 g of afﬁnity-puriﬁed antibody was incubated with 50 l
rotein-G agarose beads for 10 min  at room temperature, after 3
imes washes with antibody bind/wash buffer, 800 g nuclear pro-
eins were added for incubation at 4 ◦C overnight. The agarose beads
ere collected by pulse centrifugation, the supernatant was dis-
arded and beads were washed 3 times with 200 l IP wash buffer.
inally, immunoprecipitated proteins were subjected to SDS-PAGE
ollowed by Western blot with indicated primary antibody. Mean-
ime, Western blot analyses of nuclear proteins served as‘input’.
.4. Chromatin immunoprecipitation assays
Chromatin immunoprecipitation assays (ChIP) were performed
sing a kit from Cell Signalling Technology according to the pro-
ocol supplied. In brief, cells were ﬁxed with 1% formaldehyde
n PBS to crosslink chromatin. Cell lysates were prepared and
igested by micrococcal nuclease to break chromatin DNA rang-
ng ∼150–900 bp on average. After a preclearing step, IP was
arried out at 4 ◦C overnight with anti-smad2 antibody or nor-
al  rabbit IgG (negative control antibody). Immune complexes
ere collected with protein-G magnetic beads. After extensive
ashing, the immunoprecipitated complexes were eluted and
rotein-DNA crosslinks were reversed by incubating at 65 ◦C for
 h. DNA was puriﬁed using proteinase K digestion and col-
ected using DNA Clean-Up Column. For the Smad binding site
t position +247 of the mouse ILK promoter, the +219 and
289 region was ampliﬁed by real-time PCR with the primer
airs set: 5′-GCTGACACCACTCGGGAAAC −3′ (forward) and 5′-
GAGGTGTCAGTGTGGGATG-3′ (reverse). The amount of ILK pro-
oter that was present in the IP and input fractions was calculated
rom the standard curve. The input represents 2% of the material
sed in the IP assay. The results were expressed as the IP/input
atios of the PCR products that were used for comparison.
.5. Western blot analysis
The whole cell lysates were prepared using RIPA buffer (Sigma)
upplemented with protease inhibitor cocktails (Merk). The pro-
ein samples were quantiﬁed using the BCA protein assay reagent,
esolved by 12% SDS–PAGE gel electrophoresis and transferred to
VDF membranes. The membranes were immersed in 5% skim
ilk at room temperature for 1 h, and then overnight at 4 ◦C
ncubated with indicated primary antibodies at 1:1000 dilution
nless otherwise indicated: E-cad, Vimentin, ILK, Beclin 1, LC-3,
leaved-caspase 3, Histone H3, Phospho-Smad2 (Ser465/467), Src,
hospho-Src (Tyr 416), Myc, GAPDH (1:3000) (Cell Signalling Tech-
ology), Snail, Phospho--catenin (Y654) (1:100, Abcam), -actin
1;5000, Sigma). The bound antibodies were detected using corre-
ponding horseradish peroxidase-conjugated secondary antibodies
nd chemiluminescence detection kit (Thermo Scientiﬁc). Quan-
iﬁcation was performed by measurement of the intensity of the
ignals with image software (Image-Pro Plus 6.0) by quantifying
he relative expression of target protein versus -actin, GAPDH or
istone H3..6. Reverse transcript—polymerase chain reaction (RT-PCR)
RNA was extracted from 1 × 108 C1.1 cells treated with 3-
A,  rapamycin in the presence or absence of TGF-1 using Trizolemistry & Cell Biology 76 (2016) 123–134 127
reagent and the ﬁrst strand of cDNA was  synthesized using the
RevertAid First Strand cDNA Synthesis Kit (Thermo Scientiﬁc, USA).
The mouse E-cadherin, snail and -actin were ampliﬁed via poly-
merase chain reaction (PCR) from the ﬁrst strand of cDNA. The
forward primer of E-cadherin was 5′-CGATTCAAAGTGGCGACA-
3′, the reverse primer was  5′- TTGGATTCAGAGGCAGGGT-3′; the
forward primer of snail was 5′-CGTGTGTGGAGTTCACCTT-3′, the
reverse primer was  5′-TACCAGGAGAGAGTCCCAGA-3′; the forward
primer of -actin was 5′-CACGATGGAGGGGCCGGACTCATC-3′, the
reverse primer was  5′-TAAAGACCTCTATGCCAACACAGT-3′. PCR
ampliﬁcation was  performed with initial denaturation at 94 ◦C for
5 min  followed by 30 consecutive cycles of denaturation at 94 ◦C
for 30 s, annealing at 58 ◦C for 15 s, and extension at 72 ◦C for 20 s,
and then a ﬁnal extension at 72 ◦C for 3 min. The ampliﬁed products
were analysed by electrophoresis on a 1.5% (w/v) agarose gel.
2.7. Statistical analysis
Western blot, and immunoﬂuorescence staining were all
repeated at least three times independently. Comparisons between
groups were performed with one-way analysis of variance
(ANOVA) using the Prism software (Version 5, GraphPad), followed
by Student’s t-test. Differences were considered statistically signif-
icant at a P value less than 0.05.
3. Results
3.1. TGF-ˇ1 induces autophagy and EMT in C1.1 cells
TGF-1 can induce EMT  in C1.1 cells. (Tian et al., 2013). To
explore whether TGF-1-induced EMT  involves autophagy, we
examined the levels of Beclin 1 and LC3-II in TGF-1-stimulated
C1.1 cells by immunoﬂuorescence staining. As illustrated in Fig. 1A,
the levels of Beclin 1 and LC3-II were increased. Meanwhile, we
found that E-cadherin was  decreased and vimentin was increased
with TGF-1 treatment, consistent with EMT  (Fig. 1A). To conﬁrm
these results, Beclin 1, LC3-II and p62 were assessed by immunoblot
analysis. As shown in Fig. 1B, we observed an increase in Beclin
1 and LC3-II expression and a decrease in p62 expression which
accompanied EMT  (decreased E-cadherin and increased vimentin
expression). TGF-1 can induce apoptosis in human renal tubular
epithelial cells (Zheng et al., 2013). To assess whether apoptosis
was induced during TGF-1-induced autophagy and EMT  in C1.1
cells, apoptosis was analysed using Western blot with the cleaved-
caspase 3 antibody and ﬂow cytometry. As shown in Fig. 1B and
Suplementary Fig. 1, there was no apoptosis in C1.1 cells treated
with or without TGF-1.
To further assess the effect of TGF-1 on the induction of
autophagy and EMT, we conducted both concentration and time
course studies in C1.1 cells. We  found that TGF-1 induced
autophagy and EMT  in C1.1 cells in both a dose-dependent and
time-dependent manner (Fig. 2A and B). In addition, Western blot
analysis also showed that the increased levels of Beclin 1 were
present at 12 h after TGF-1 treatment, while autophagosome
protein LC3 II increased at 24 h indicative of initiation of autophago-
cytosis. However, E-cadherin and vimentin were not altered until
after 24 h of TGF-1 treatment. Therefore, it appears that TGF-1
induced autophagy prior to EMT  in C1.1 cells.
3.2. Autophagy promotes TGF-ˇ1 induced-EMT in C1.1 cellsTo characterize the relationship between autophagy and EMT,
C1.1 cells were treated with TGF-1 combined with 3-MA (an
autophagy inhibitor), (Pliyev and Menshikov, 2012) chloroquine
(CQ, an autophagy inhibitor) (Schonewolf et al., 2014) or rapamycin
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Fig. 4. E-cadherin was degraded via autophagy-lysosomal pathways in TGF-1-treated C1.1 cells. C1.1 cells were pretreated with or without 20 mM NH4Cl (A), 10 M CQ (B)
or  10 M MG132 (C) in presence or absence of 5 ng/ml TGF-1 for 24 h (NH4Cl and CQ) or for 6 h (MG132), then treated with or without 5 ng/ml TGF-1 alone for another 24 h.
DMSO  was  used in control group. After treatment, total proteins were extracted, and the levels of E-cad and -actin were detected by Western blotting. Blots representative
of  three independent experiments are shown. Data are mean ± SD (n = 3) of three independent experiments. *p < 0.05.
Fig. 5. Autophagy promotes -catenin nuclear translocation and phosphorylation. C1.1 cells were pretreated with or without 5 M 3-MA (A) or 45 nM rapamycin (B) in
serum-free medium for 24 h, then treated with or without 5 ng/ml TGF-1 for another 2 h. DMSO was used in control group. After treatment, total proteins, cytoplasmic
proteins and nucleoproteins were extracted, the levels of -catenin, pY654--catenin, p-Smad2, -actin, GAPDH and histone H3 were detected by Western blotting. Blots
representative of three independent experiments are shown. Data are mean ± SD (n = 3) of three independent experiments. *p < 0.05.
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Fig. 6. Autophagy promotes TGF-1-induced phosphorylation of Src. C1.1 cells were pretreated with or without 5 M 3-MA (A), siRNA for Beclin 1 (B) or 45 nM rapamycin (C)
in  serum-free medium for 24 h, then treated with or without 5 ng/ml TGF-1 for another 2 h. DMSO was  used as a vehicle in control group. After treatment, total proteins were
extracted, the levels of p-Src (Tyr416) and -actin were detected by Western blotting. Blots representative of three independent experiments are shown. Data are mean ± SD
(n  = 3) of three independent experiments. *p < 0.05. (D) C1.1 cells were cultured on glass coverslips and pretreated with or without 5 M 3-MA or 45 nM rapamycin in
serum-free medium for 24 h, then treated with or without 5 ng/ml TGF-1 for another 2 h. DMSO was used in control group. After treatment, p-Src (Tyr416) levels were
detected by immunoﬂuorescence staining analysis. Scale bar, 25 m.
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an autophagy inducer) (Harada et al., 2008). We  found that 3-
A  and CQ clearly suppressed autophagy in TGF-1-stimulated
1.1 cells, while the level of EMT  was also decreased (Fig. 3A and
). Autophagy was previously reported promoting EMT  Zhu et al.,
014. In our study, we found that rapamycin alone could induce
utophagy and importantly augmented the EMT  induced by TGF-
1 (Fig. 3C). Furthermore, we measured the E-cad and Snail mRNA
evels in the same conditions. We  found that neither 3-MA nor
apamycin alone altered E-cad mRNA expression but did so when
ombined with TGF-1 treatment (Supplementary Fig. 2). This
esult suggests that the reduction of E-cadherin protein (Fig. 3C)
as likely due to autophagy degradation of the E-cadherin protein.
eanwhile, the morphology of the C1.1 cells treated with 3-MA
r rapamycin in presence or absence of TGF-1 was observed. We
ound that rapamycin enhanced TGF-1-induced EMT  morpholog-
cal change from cuboid clustered epithelial cells to spindle-shaped
cattered ﬁbroblast-like cells, whilst 3-MA had a reverse effect
Supplementary Fig. 3).
In addition, we used small interfering RNA (siRNA) to knock-
own Beclin 1 in TGF-1-treated C1.1 cells. The results showed
hat EMT  was inhibited when Beclin 1 was downregulated (Fig. 3D).
o further address the biological effects of autophagy on EMT, we
nalysed autophagy and EMT  using serum rescue assay in TGF-
1-treated C1.1 cells. After 48 h of TGF-1 treatment, serum-free
edium was replaced with complete medium and serial sam-
les were assessed using Western blot assay. As shown in Fig. 3E,
eclin 1 and LC3-II were obviously decreased at 45 min  indicat-
ng that autophagy was inhibited, whereas changes in E-cadherin
nd Vimentin were not seen until 90 min  and 180 min, respectively.
evertheless, serum rescue inhibited autophagy followed by rever-
al of EMT. These results demonstrate that autophagy precedes EMT
nd it can promote TGF-1-induced EMT  in C1.1 cells.
.3. E-cadherin is degraded via the autophagy-lysosomal
athway in TGF-ˇ1-treated C1.1 cells
Reduction or loss of E-cadherin expression is one of the
ell-established hallmarks of EMT  (Thiery et al., 2009). Besides
ranscriptional regulation, E-cadherin can be degraded via pro-
easome (Zhou et al., 2011) or autophagy-lysosomal pathways
Strisciuglio et al., 2013). Given the concomitant decrease of
-cadherin and increase of LC3 II at 24 h (Fig. 2B), we then
xamined whether E-cadherin can be degraded via autophagy-
ysosomal pathway in TGF-1-induced EMT. As shown in Fig. 4,
-cadherin was decreased with TGF-1 treatment, whereas when
he inhibitors of autophagy-lysosomal pathway including ammo-
ium chloride (NH4Cl) or chloroquine were added, the reduction
f E-cadherin was rescued. However, when MG132, an inhibitor
f proteasome was added, TGF-1-induced decrease of E-cadherin
as unchanged. The levels of E-cadherin protein were not changed
y NH4Cl, chloroquine or MG132 alone treatments. Together with
esult of E-cadherin mRNA levels examined, these data suggest that
utophagy can degrade E-cadherin in augment of TGF-1-induced
MT in C1.1 cells.
.4. Autophagy promotes ˇ-catenin nuclear translocation and
hosphorylation
Given that TGF-1-induced autophagy degraded E-cadherin
Fig. 4), we hypothesized that the E-cadherin associated -catenin
ould potentially translocate into the nucleus. To test this, we
xtracted cytoplasmic and nuclear proteins to examine the dis-
ribution of -catenin in the presence of an inducer or inhibitor
f autophagy in TGF-1-treated C1.1 cells. As shown in Fig. 5,
-catenin in both cytoplasm and nucleus was decreased in TGF-
1 and 3-MA treated C1.1 cells, whereas cytoplasmic and nuclearemistry & Cell Biology 76 (2016) 123–134
-catenin was  increased when C1.1 cells were treated with
TGF-1 and rapamycin. It is reported that TGF-1 stimulates -
catenin phosphorylation at tyrosine 654 (pY654--catenin) which
plays an important role in inducing pulmonary ﬁbrosis; (Ulsamer
et al., 2012) therefore, we wanted to know whether autophagy
could increase -catenin phosphorylation in TGF-1-treated C1.1
cells. We  showed that -catenin phosphorylation at Tyr-654 was
repressed when C1.1 cells were treated with autophagy inhibitor
3-MA in the presence of TGF-1, whereas, autophagy inducer
rapamycin augmented phosphorylation at the same site (Fig. 5).
In all these experiments, we also found that TGF-1 induced phos-
phorylation of Smad2, however autophagy had no effect on the
p-Smad2 levels.
Src family kinase activation is reported downstream of TGF-
1 to phosphorylate -catenin at Y654 in several models (Piedra
et al., 2001; Ulsamer et al., 2012). In the current study, we found
that TGF-1 induced autophagy and autophagy in turn promoted
-catenin phosphorylation at Y654. Therefore we tested whether
autophagy inﬂuences the activity of Src. Western blot showed
that autophagy inhibitor 3-MA or Beclin 1 siRNA repressed p-Src
levels, whereas autophagy inducer rapamycin increased p-Src lev-
els (Fig. 6A–C). Immunoﬂuorescence staining also showed that
3-MA decreased while rapamycin increased p-Src levels (Fig. 6D).
Thereby, autophagy disrupted the E-cadherin-mediated cell–cell
contacts by both degradation of E-cadherin and Src phosphoryla-
tion of -catenin at Y654.
3.5. Autophagy-promoted ILK expression is dependent on
ˇ-catenin/Smad2 pathways in TGF-ˇ1-treated C1.1 cells
Integrin linked kinase (ILK) has an essential role in controlling
the process of EMT, especially in TGF-1-induced EMT  (Serrano
et al., 2013). We  next examined whether ILK is linked to autophagy
in TGF-1-induced EMT  in C1.1 cells. We  analysed the expression
of ILK in the presence of autophagy induction or inhibition. Anal-
ysis of Beclin 1 and LC3-II levels in TGF-1-treated cells showed
a decline in LC3-II with 3-MA, indicative of decreased autophagic
ﬂux; in addition, we  found that the ILK level was reduced (Fig. 7A)
and EMT  was  suppressed (E-cadherin increased, vimentin and
snail decreased, Supplementary Fig. 4A). In contrast, rapamycin
caused increases in Beclin 1 and LC3-II levels in the presence of
TGF-1, consistent with the augmentation of autophagy, while
ILK level was  increased (Fig. 7B) and EMT promoted (E-cadherin
decreased, vimentin and snail increased, Supplementary Fig. 4B).
Our results also showed that the expression of ILK was  decreased
when autophagy was  inhibited by siRNA silencing of Beclin 1
(Fig. 7C). These results demonstrated that autophagy promotes ILK
expression in TGF-1-treated C1.1 cells.
It has been shown that ILK expression in tubular epithelial
cells (TECs) can be induced via the TGF-/Smad pathway (Liu,
2010) and that Smad-dependent transcription is further depen-
dent on coactivators which stabilize Smad association with DNA
such as that of -catenin (Tian et al., 2013). To test whether
TGF-1/Smad pathway and -catenin are both involved in ILK
expression in TGF-1-treated C1.1 cells, we transfected Smad7
and F-TrCP-Ecadplasmid (which preferentially targets soluble
nuclear/cytosolic -catenin for degradation; Tian, et al., 2013) into
C1.1 cells; we  found that ILK was  decreased with Smad7 and F-
TrCP-Ecad treatment in presence of TGF-1 (Fig. 7D and E). In
addition, we also found that the blockade of TGF −1/Smad path-
way and degradation of -catenin also suppressed TGF-1-induced
autophagy. In accordance, EMT  was suppressed as shown in Sup-
plementary Fig. 4C and D, and levels of -catenin in cytoplasm and
nucleus decreased in F-TrCP-Ecad transfected C1.1 cells as shown
in Supplementary Fig. 4E and F.
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Fig. 7. Autophagy promotion of ILK expression is dependent on -catenin/Smad2 pathways. C1.1 cells were pretreated with or without 5 M 3-MA (A), 45 nM rapamycin
(B)  or siRNA for Beclin 1 (C) in serum-free medium for 24 h, then treated with or without 5 ng/ml TGF-1 for another 48 h. DMSO was used as a vehicle in control group. After
treatment, total proteins were extracted, the levels of Beclin 1, LC3-II, ILK and -actin were detected by Western blotting. C1.1 cells were transfected with pcDNA3-Smad7
plasmid (D) or F-TrCP-Ecad plasmid (E) for 24 h. pcDNA3 plasmid was  used in control. 24 h later, cells were treated with or without 5 ng/ml TGF-1 for another 48 h. After
treatment, total proteins were extracted, the levels of Beclin 1, LC3-II, ILK, Smad7 (Myc tag) and -actin were detected by Western blotting. Blots representative of three
independent experiments are shown. Data are mean ± SD (n = 3) of three independent experiments. *p < 0.05.
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Fig. 8. Autophagy promotes Smad2 binding to the promoter of ILK and pY654--
catenin/p-Smad2 complex formation. (A) A schematic diagram of the ILK promoter
that  contains the identiﬁed Smads binding site. (B) C1.1 cells were pretreated with
or  without 5 M 3-MA or 45 nM rapamycin in serum-free medium for 24 h, then
treated with or without 5 ng/ml TGF-1 for another 2 h. After treatment, cells
were cross-linked with formaldehyde (ﬁnal 1%) for 10 min  at room temperature
and then subjected to chromatin immunoprecipitation using speciﬁc anti-Smad2
antibody or normal rabbit IgG (negative control). The amount of immunoprecipi-
tated DNA in each sample was detected by real-time PCR using respective primers
and  represented as signal relative to the total amount of input chromatin (equiv-
alent to 1). C1.1 cells were pretreated with or without 5 M 3-MA (C) or 45 nM
rapamycin (D) in serum-free medium for 24 h, then treated with or without 5 ng/ml32 M. Pang et al. / The International Journal of
To further conﬁrm the effect of autophagy on the transcrip-
ional regulation by Smad2 of ILK expression in TGF-1-treated
1.1 cells, a transcription factor binding site screen was  performed
sing the online software (http://rulai.cshl.edu/cgi-bin/TRED/tred.
gi?process). Sequence analysis revealed a Smad binding sequence
GTCT) (Shi et al., 1998) located in the region from +247 to +250 of
he mouse ILK promoter (Fig. 8A). ChIP assays using Smad2 anti-
ody revealed that the interaction of Smad2 with the promoter
equence of ILK gene was increased with TGF-1 treatment, while
-MA treatment decreased and rapamycin increased this interac-
ion in TGF-1-treated C1.1 cells (Fig. 8B). Normal rabbit IgG had no
ffect on recruitment of the promoter of mouse ILK gene, excluding
onspeciﬁc precipitation by the Smad2 antibody.
We presume that autophagy can promote the formation of
Y654--catenin/p-Smad2 complexes which stabilize p-Smad2
inding to ILK promoter. To test this hypothesis, we performed
o-immunoprecipitation (Co-IP) assays using p-Smad2 antibody.
s shown in Fig. 8C and D, TGF-1 treatment increased pY654-
-catenin binding to p-Smad2, and 3-MA suppressed while
apamycin further increased their binding. Notably, neither the
utophagy inhibitor nor inducer change phospho-Smad2 levels.
hese data demonstrate that autophagy promotes pY654--
atenin/p-Smad2 complex formation, thereby increasing p-Smad2
inding to the ILK promoter to upregulate ILK expression.
. Discussion
Autophagy is an evolutionally conserved cellular “self-eating”
rocess through which cells digest their own contents via lyso-
omal machinery, thereby providing energy and building blocks
or cell survival. Autophagy has been implicated in organ ﬁbro-
is, including kidney ﬁbrosis (Hernandez-Gea et al., 2012; Koesters
t al., 2010). EMT  is known to contribute to the progression
f kidney ﬁbrosis. Yet the relationship between autophagy and
MT is unclear. Koesters et al. (2010) found that TGF-1 induced
utophagy and led to the development of tubulointerstitial ﬁbrosis
ithout evidence of EMT  in a transgenic mouse model with over-
xpression of TGF-1 in kidney tubular epithelial cells. Whereas
ing et al. (2014) found that the autophagy impairment (Beclin 1
eterozygous mice) led to an increased collagen deposition in the
bstructed kidneys after unilateral ureteral obstruction. That the
nterrelationship between autophagy and EMT  remains controver-
ial, may  be explained by its dependence on cellular context. Some
tudies have sho wn that autophagy can attenuate EMT  (Lv et al.,
012) while others found that autophagy activated EMT  (Li et al.,
013). Whether autophagy is upstream or downstream of EMT  is
lso unclear (Akalay et al., 2013). Our study provides the ﬁrst evi-
ence that autophagy induced by TGF-1 promotes EMT  through a
ovel pY654--catenin/pSmad2 upregulation of ILK, and therefore
ontributes to kidney ﬁbrosis.
In this study, we identiﬁed a Smad binding element (SBE) in the
′ upstream regulatory region of ILK as important for TGF- regula-
ion of the ILK gene. The 8 bp sequence of GTCTAGAC was  originally
dentiﬁed as a SBE (Zawel et al., 1998). The sequence of SBE varies
n different genes, for example, the SBE sequence is GTCTGGAC in
he RGC-32 promoter (Huang et al., 2011). Using crystal structure
nalysis, Shi et al. (1998) revealed that a 4 bp Smad box-GTCT is
ufﬁcient for binding by Smads. Accordingly, we screened the ILK
romoter from −2000 to +299 online (https://cb.utdallas.edu/cgi-
in/TRED/tred.cgi?process=home) and found a GTCT Smad box at
247 to +250. ChIP assay using Smad2 antibody demonstrated that
GF-1 could increase the interaction of Smad2 with the ILK pro-
oter and thereby ILK expression. This interaction was repressed
hen autophagy was inhibited (Fig. 6). These results showed that
utophagy promotes the transcription of ILK by TGF-1/Smad2.
TGF-1  for another 2 h. DMSO was used in control group. After treatment, co-
immunoprecipitation of pY654--catenin and P-Smad2 from cell nuclear proteins
was  performed using rabbit P-Smad2 antibody. Normal rabbit IgG was used as
a  negative control. Immunoprecipitates were analysed by western blotting with
anti-pY654--catenin and anti-P-Smad2 antibodies. Quantiﬁcation of immunoblots
(relative intensity) is shown by fold increase in densitometry intensity (the intensity
of  the control is arbitrarily deﬁned as 1). Immunoblots representative of three inde-
pendent experiments are shown. Data are mean ± SD (n = 3) of three independent
experiments. *p < 0.05.
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TGF-1/Smad signaling or Smad-dependent transcription is
ependent on co-activators such as -catenin that stabilize Smad
ssociation with DNA (Kim et al., 2009b; Tian et al., 2013). -
atenin is both a structural component of adherens junctions and
n intracellular signaling molecule when it translocates to the
ucleus. TGF-1 has been shown to induce -catenin phosphory-
ation (at Y654) and complex with p-Smad2 to promote idiopathic
ulmonary ﬁbrosis (Kim et al., 2009a; Ulsamer et al., 2012). Our
revious study showed that -catenin can bind to p-Smad3 and as
 transcriptional co-activator promote TGF-1-induced EMT  (Tian
t al., 2013). In the present study, we found that -catenin was
issociated from E-cadherin when E-cadherin was degraded by
utophagy, and probably more important by autophagy-dependent
rc kinase phosphorylation at Y-654 to promote its stabilization
nd complex with p-Smad2.
Both ILK and pY654--catenin/pSmad2 have each individually
een shown to induce EMT  and ﬁbrosis arising from both lung alve-
lar and kidney tubular epithelial cells (Kim et al., 2009a; Tian et al.,
013; Ulsamer et al., 2012). However, ILK has never been linked
o pY654--catenin/pSmad2 in either EMT  or autophagy. More
mportantly, whether ILK functions differently via different path-
ays between its physiological action and in TGF--induced EMT
s unknown. Our current study provided evidence that increased
xpression of ILK was responsible for TGF-1-induced EMT, a role
hat may  differ from the essential role of ILK in normal cell-matrix
nteraction and function at the physiological level. Identiﬁcation
f the cellular location of ILK and its binding partners may  pro-
ide a clue for understanding the different roles of ILK. Tubular
ell EMT  is a highly regulated process in which tubular epithe-
ial cells lose E-cadherin and acquire mesenchymal features (Yang
nd Liu, 2001). Disruption of E-cadherin-mediated cell–cell con-
act has been found to be critical for TGF-1-induced EMT  (Masszi,
t al., 2004; Zheng et al., 2009). We  found for the ﬁrst time that
GF-1-induced autophagy links pY654--catenin/pSmad2 to ILK
xpression via disruption of E-cadherin/-catenin in cell–cell con-
act, thereby promoting EMT.
Our results showed that C1.1 cells were induced to autophagy
ut not apoptosis. This could possibly be explained by ILK activation
f Akt which suppresses apoptosis. By this mechanism, TGF-1-
nduced autophagy (which promotes EMT) is a survival mechanism
or C1.1 cells under starvation and TGF-1 stimulation, for EMT  was
ot induced until 48 h of TGF-1 treatment and serum rescued both
utophagy and EMT.
In summary, our current study demonstrated that TGF-1-
nduced autophagy promoted the degradation of E-cadherin which
eleased -catenin, while autophagy-activate Src in turn phospho-
ylated -catenin for -catenin nuclear translocation and complex
ith pSmad2 in upregulation of ILK expression, and thereby EMT.
he pY654--catenin/pSmad2/ILK pathway logically links TGF-
1-induced autophagy and EMT  via degradation of E-cadherin.
herefore, targeting autophagy and this pathway may  attenuate
MT  to prevent ﬁbrosis in kidney and other organs.
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